1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Liu Xiufeng: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adebrelimab and Chidamide for Pancreatic Cancer Adebrelimab and Chidamide Combined with Gemcitabine and S1 - Pancreatic Cancer, Adult | Phase 2 | Recruiting | Liu Xiufeng | 45 | 2024-09-10 | 2025-12-08 |
Pancreatic Neoplasms (1) · Pancreatic cancer, adult (1)
Gemcitabine (1) · S 1 (combination) (1)
China (1)